Alaunos Therapeutics (TCRT) Cash from Operations (2009 - 2026)
Alaunos Therapeutics (TCRT) reported Cash from Operations of 1031000.0 for Q1 2026, down 33.55% on a YoY basis from 1551524.37 in Q1 2025, and down 86.78% quarter-over-quarter from 552000.0 in Q4 2025.
Alaunos Therapeutics (TCRT) Cash from Operations (2009 - 2026) Analysis & Trends
Alaunos Therapeutics has reported Cash from Operations for 18 years, with the latest figure at 1031000.0 in Q1 2026.
- For the quarter ending Q1 2026, Cash from Operations fell 33.55% year-over-year to 1031000.0; the trailing twelve-month figure through Mar 2026 stood at 3128000.0 (up 18.24% YoY), and the FY2025 full-year result was 2869000.0, up 42.29% from the prior year.
- Cash from Operations for Q1 2026 stood at 1031000.0, down from 552000.0 in the prior quarter.
- The five-year high for Cash from Operations was 552000.0 in Q4 2025, with the low at 9381000.0 in Q1 2023.
- Historically, Cash from Operations has averaged 4014411.76 across 5 years, with a median of 1917000.0 in 2024.
- Annual changes were most pronounced in 2024 — Cash from Operations surged 91.98% — and 2026, when it tumbled 33.55%.
- Alaunos Therapeutics' Cash from Operations stood at 7130000.0 in 2022, then slipped by 3.58% to 7385000.0 in 2023, then surged by 91.98% to 592000.0 in 2024, then advanced by 6.76% to 552000.0 in 2025, then sank by 86.78% to 1031000.0 in 2026.
- The last three Cash from Operations figures came in at 1031000.0 (Q1 2026), 552000.0 (Q4 2025), and 844000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.49 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.43 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Alaunos Therapeutics | 4.31 Mn | 3.95 Mn | - | -1.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.03 Mn |
| Mar 31, 2026 | -1.03 Mn |
| Dec 31, 2025 | -552,000.00 |
| Dec 31, 2025 | -552,000.00 |
| Sep 30, 2025 | -844,000.00 |
| Sep 30, 2025 | -844,000.00 |
| Jun 30, 2025 | -701,000.00 |
| Jun 30, 2025 | -701,000.00 |
| Mar 31, 2025 | -772,000.00 |
| Mar 31, 2025 | -772,000.00 |
| Dec 31, 2024 | -592,000.00 |
| Dec 31, 2024 | -592,000.00 |
| Sep 30, 2024 | -781,000.00 |
| Sep 30, 2024 | -781,000.00 |
| Jun 30, 2024 | -1.68 Mn |
| Jun 30, 2024 | -1.68 Mn |
| Mar 31, 2024 | -1.92 Mn |
| Mar 31, 2024 | -1.92 Mn |
| Dec 31, 2023 | -7.39 Mn |
| Dec 31, 2023 | -7.39 Mn |